Teva Pharmaceutical Industries Limited
$41.50
+0.39 (+0.95%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- +5.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -5.4%
Own TEVA?
See how TEVA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.